Xunde Xian, Professor at the Peking University Institute of Cardiovascular Sciences, Ph.D. supervisor, Principal Investigator of the State Key Laboratory of Vascular Homeostasis and Remodeling, Director of the Laboratory for Lipid Metabolism Disorders and Metabolic Cardiovascular Diseases, recipient of the National High-Level Overseas Talent Youth Program, and Boya Young Scholar at Peking University.

   His research interest focuses on lipid metabolism regulation and metabolic cardiovascular diseases. His laboratory has established a series of genetically-engineered hamster models for lipid metabolism disorders with independent intellectual property rights in China. He has published more than 60 research articles in internationally renowned journals such as Circulation Research, ATVB, PNAS, eLife, Science Signaling, EBioMedicine, and Metabolism.

   Dr. Xian has been receipted many awards include the Outstanding Young Talent Award from the Chinese Association for Laboratory Animal Sciences in 2020, the First Prize of the Beijing Medical Association Science and Technology Award in 2022, and the Second Prize of the Beijing Association for Science and Technology Natural Science and Technology Award. A total of 11 international and national patents have been granted.

   He is currently serving as an executive member of the Arteriosclerosis Committee of the Chinese Society of Pathophysiology, Vice Chair of the Chinese Branch of the International Atherosclerosis Society, and on the editorial boards of Atherosclerosis and Scientific Reports. Additionally, he is an invited reviewer for journals such as Nature Cell Biology, Nature Communications, Journal of Clinical Investigation, and PNAS.